In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1822 News Items found
MSK breast cancer patient Majiel Baker is seen at the beach with her husband and children.
Cancer Care Worth Traveling For: Why People Come to MSK From Across the Country

Learn why over 5,000 people a year travel more than 150 miles to MSK for cancer care, including resources for the specific needs of traveling patients and their loved ones.
Breast medical oncologist Sherry Shen is seen smiling outdoors.
Cancer Benefits and Risks From Ozempic, Wegovy, and Other Weight Loss Drugs

Learn what Zepbound, Wegovy, Ozempic and other weight loss drugs mean for cancer risk and treatment, from an expert at MSK.
Q&A
Dr. Omar Abdel-Wahab in his lab
Meet Omar Abdel-Wahab: A 2025 Paul Marks Prize Recipient 

A leader in developing better treatments for a range of blood cancers, Dr. Omar Abdel-Wahab is only the second person from MSK to receive the Paul Marks Prize for Cancer Research. 
Jack Georgakis is seen wrestling in a martial arts class.
FDA Approves Adding Durvalumab Immunotherapy to Prevent Stomach and Esophageal Cancer Recurrence

Learn about a new approach helping to reduce the risk of stomach and esophageal cancer coming back after surgery, which has been approved by the FDA thanks to a clinical trial with immunotherapy led by researchers at MSK.
MSK patient Karren Tyler poses in front of a portrait of two dogs
Able To Speak After Tongue Cancer, Thanks to a Second Opinion at MSK and a Partial Glossectomy

Thanks to a second opinion and minimally invasive surgery at MSK to remove tongue cancer, Karren Tyler is back home in Charlottesville, Virginia, cancer free and focused on giving back to other cancer patients.
Dr. Charles Rudin
FDA Grants Full Approval to Lung Cancer Drug Tarlatamab Based on Trial Led by MSK Researcher

The U.S. Food and Drug Administration (FDA) has granted full approval to the drug tarlatamab, a bispecific T cell engager, for small cell lung cancer, based on results from a phase 3 clinical trial led by Dr. Charles Rudin at MSK.
Feature
Man with gray hair sits in a doctor's office looking worried
How To Stop the Fear of Cancer

Learn more about five essential strategies for coping with the fear of cancer, from MSK psychiatrist Dr. Monique James.
Lab coat with the MSK logo hangs in a lab
MSK Research Highlights, November 20, 2025

New MSK research finds a potential therapeutic opportunity in regulatory T cells’ resilience to the loss of Foxp3; shows how cancer develops resistance to antibody-drug conjugates; develops a new system to help make gene editing safer and more reliable; and shows provider billing margin doesn’t drive cancer treatment selection.
A researcher points to cells on a screen
Memorial Sloan Kettering Cancer Center Applauds Highly Cited Researchers 2025

In 2025, MSK was again ranked among the top organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers, published by the Institute for Scientific Information at Clarivate.
Microscope in foreground. GSK Graduate Students in the background.
Training Tomorrow’s Leaders: Graduate Education at GSK

Since its founding 19 years ago, the Gerstner Sloan Kettering Graduate School of Biomedical Sciences has attracted bright minds drawn to its connection to MSK. Learn more about how we're training tomorrow's leaders.